As the Head of Calyx Musculoskeletal Imaging, Dr. Warner applies her 25+ years of medical imaging research experience and the expertise she’s gleaned from supporting over 200 imaging trials to help pharmaceutical companies and CROs succeed. She holds certifications by the International Society for Clinical Densitometry (ISCD) as a Clinical Densitometrist and a DXA technologist as well as a Radiology Practicing Technologist License in the state of Utah. Dr Warner’s musculoskeletal research has included the use of many different modalities for the assessment of bone metabolism including bone histomorphometry, 3-point bending, radiography, ultrasound, DXA, QCT, and high-resolution CT imaging.
Leveraging her training in medicine and radiology, Surabhi has led the imaging components of approximately 50 oncology trials – both solid tumors and hematology malignancies – and provided consultation on complicated aspects of standardized response assessment criteria. Her expertise in Multiple Myeloma, Lymphoma, and CLL enables her to provide clear guidance to clinical trial sponsors and communicate complexities of criteria to independent reviewers to avoid heterogeneity.
In leading the imaging component of oncology studies for Calyx’s global customers, Oliver leverages his experience from supporting over 600 clinical trials – with various indications, complexities, and in all phases of development – which led to the approval of over 20 oncology treatments. He is co-author of the immune-related response criteria (irRC, 2009), first author of irRECIST (2014), and co-author of Comparison of Assessments using RECIST and irRECIST by Manitz J. et al. (2020).
As a Medical Writer at Calyx, Sally Han develops Independent Review Charters (IRCs), clinical data forms, results reports, and other protocol-specific documents in support of independent review. Leveraging her training in pharmacy and English‑Chinese interpreting, she has provided support on Chinese and global clinical trials. Prior to joining Calyx, Sally was a Medical Copywriter at a private hospital in Shanghai, where she created and translated physician-related policies, SOPs, medical record templates and other documents.
As a Senior Medical Writer with Calyx since 2020, Paivi is responsible for creating independent review charters and other clinical documents intended for submission to regulatory authorities on behalf of Calyx’s clients. She leverages her extensive experience to provide subject matter expertise to sponsor teams conducting imaging clinical trials across various therapeutic areas such as neurology, oncology, ophthalmology, and cardiology. Paivi has authored more than 15 peer reviewed publications in such prestigious journals as the Journal of Neuroscience, the Journal of Neurophysiology, and Frontiers in Molecular Neuroscience.
Since joining Calyx in 2009, Katarina has had multiple, escalating roles in the department of medical writing. She leverages her extensive medical writing experience to create comprehensive and reliable Independent Review Charters, including those intended for regulatory submission. Her expertise spans multiple indications across a wide array of therapeutic areas, including oncology, CNS, and musculoskeletal disease states, with a strong emphasis in haemato-oncology. A dedicated medical writing professional, Katarina is frequently featured at industry conferences and has published numerous times in peer-reviewed journals.
